Exploring the complexities of bioprospecting, this anthropological study delves into the interactions between Mexican scientists and American pharmaceutical companies as they seek medicinal plants and indigenous knowledge. It critically examines the promises of royalties and community development, questioning whether these corporate practices genuinely benefit conservation and indigenous rights. The book raises essential inquiries about the distribution of profits and the stakeholders involved, revealing the nuanced dynamics at play in the pursuit of biodiversity and medicinal advancements.
